Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Cowan

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 24, 2001
Geometric visual hallucinations, Euclidean symmetry and the functional architecture of striate cortexP C Bressloff, J D Cowan, M Golubitsky, et al.
Cancer Drug Delivery|January 1, 1984
Predictive value of trypan blue exclusion viability measurements for colony formation in a human tumor cloning assayJ D Cowan, D D Von Hoff, B Neuenfeldt, et al.
Cancer Treatment Reports|March 1, 1986
Phase II trial of bisantrene in previously treated patients with ovarian carcinoma: a Southwest Oncology Group StudyJ D Cowan, E A Surwit, D S Alberts, et al.
The Journal of Nervous and Mental Disease|July 1, 1980
Defeated and joyless: potential measures of change in drug abuse characteristicsJ D Cowan, D C Kay, G L Neidert, et al.
Cancer Treatment Reports|September 1, 1982
Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group StudyJ D Cowan, D D Von Hoff, B McDonald, et al.
Investigational New Drugs|January 1, 1985
A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study)J D Cowan, C K Osborne, J A Neidhart, et al.
Investigational New Drugs|September 1, 1988
Phase II trial of five day intravenous infusion vinblastine sulfate in patients with diffuse malignant mesothelioma: a Southwest Oncology Group studyJ D Cowan, S Green, J Lucas, et al.
Investigational New Drugs|January 1, 1987
Phase II evaluation of bisantrene hydrochloride in refractory malignant melanoma. A Southwest Oncology Group StudyD S Alberts, N Mason-Liddil, S J Green, et al.
Journal of the National Cancer Institute|August 17, 1991
Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group studyJ D Cowan, J Neidhart, S McClure, et al.
Clinical Pharmacology and Therapeutics|June 29, 2012
Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotypingJ S Schildcrout, J C Denny, E Bowton, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 24, 2001
Geometric visual hallucinations, Euclidean symmetry and the functional architecture of striate cortexP C Bressloff, J D Cowan, M Golubitsky, et al.
Cancer Drug Delivery|January 1, 1984
Predictive value of trypan blue exclusion viability measurements for colony formation in a human tumor cloning assayJ D Cowan, D D Von Hoff, B Neuenfeldt, et al.
Cancer Treatment Reports|March 1, 1986
Phase II trial of bisantrene in previously treated patients with ovarian carcinoma: a Southwest Oncology Group StudyJ D Cowan, E A Surwit, D S Alberts, et al.
The Journal of Nervous and Mental Disease|July 1, 1980
Defeated and joyless: potential measures of change in drug abuse characteristicsJ D Cowan, D C Kay, G L Neidert, et al.
Cancer Treatment Reports|September 1, 1982
Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group StudyJ D Cowan, D D Von Hoff, B McDonald, et al.
Investigational New Drugs|January 1, 1985
A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study)J D Cowan, C K Osborne, J A Neidhart, et al.
Investigational New Drugs|September 1, 1988
Phase II trial of five day intravenous infusion vinblastine sulfate in patients with diffuse malignant mesothelioma: a Southwest Oncology Group studyJ D Cowan, S Green, J Lucas, et al.
Investigational New Drugs|January 1, 1987
Phase II evaluation of bisantrene hydrochloride in refractory malignant melanoma. A Southwest Oncology Group StudyD S Alberts, N Mason-Liddil, S J Green, et al.
Journal of the National Cancer Institute|August 17, 1991
Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group studyJ D Cowan, J Neidhart, S McClure, et al.
Clinical Pharmacology and Therapeutics|June 29, 2012
Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotypingJ S Schildcrout, J C Denny, E Bowton, et al.
Pageof 5